Abstract
Silicosis and coal workers' pneumoconiosis are complex multifactorial lung diseases whose etiopathogenesis are not well defined. It is generally accepted that fibrotic lung disorders are mediated by macrophage-derived cytokines and growth factors. There is evidence showing a crucial role for tumor necrosis factor-α (TNF-α) and interleukin-1 (IL-1) in inflammation caused by silica dust and in the transition from simple to progressive massive fibrosis. In this review we discuss genetic polymorphisms responsible for regulating the production of these proinflammatory cytokines and their role in modifying silicosis severity.
Similar content being viewed by others
References
Wagner GR: Asbestosis and silicosis. Lancet 349: 1311–1315, 1997
NIOSH: NIOSH alert: Request for assistance in preventing silicosis and deaths from sandblasting. Cincinnati: US Department of Health and Human Services, Public Health Service, CDC, NIOSH, DHHS publication no. (NIOSH)92–102, 1992
Legal and Medical Resource Center for Silicosis Victims; www.silicosis.com; last modified January 23, 2002
Lim Y, Kim JH, Kim KA, Chang HS, Park YM, Ahn BY, Phee YG: Silica-induced apoptosis in vitro and in vivo. Toxicol Lett 108: 335–339, 1999
Castranova V, Vallyathan V: Silicosis and coal workers' pneumoconiosis. Environ Health Perspect 108: 675–684, 2000
Kelley J: Cytokines of the lung. Am Rev Respir Dis 141: 765–788, 1990
Gauldie J, Jordana M, Gerard Cox: Cytokines and pulmonary fibrosis. Thorax 48: 931–935, 1993
Vaillant P, Menard O, Vignaud JM, Martinet N, Martinet Y: The role of cytokines in human lung fibrosis. Monaldi Arch Chest Dis 51: 145–152, 1996
Ward PA, Hunninghake GW: Lung inflammation and fibrosis. Am J Respir Crit Care Med 157: 123–129, 1998
Struhar DJ, Harbeck RJ, Gegen N, Kawada H, Mason RJ: Increased expression of class II antigen of the major histocompatibility complex on alveolar macrophages and alveolar type II cells and interleukin-1(IL-1) secretion from alveolar macrophages in an animal model of silicosis. Clin Exp Immunol 77: 281–284, 1989
Driscoll KE, Lindenschmidt RC, Maurer JK, Higgins JM, Ridder G: Pulmonary response to silica or titanium-dioxide: Inflammatory cells, alveolar macrophage-derived cytokines, and histopathology. Am J Respir Cell Mol Biol 2: 381–390, 1990
Mohr C, Gemsa D, Graebner C, Hemenway DR, Leslie KO, Absher PM, Davis GS: Systemic macrophage stimulation in rats with silicosis: Enhanced release of tumour necrosis factor-α from alveolar and peritoneal macrophages. Am J Respir Cell Mol Biol 5: 395–402, 1991
Davis GS, Pfeiffer LM, Hemenway DR: Persistent overexpression of interleukin-1beta and tumour necrosis factor-alpha in murine silicosis. J Environ Pathol Toxicol Oncol 17: 99–114, 1998
Orfila C, Lepert JC, Gossart S, Frisach MF, Cambon C, Pipy B: Immunocytochemical characterization of lung macrophage surface phenotypes and expression of cytokines in acute experimental silicosis in mice. Histochem J 30: 857–67, 1998
Piguet PF, Collart MA, Grau GE, Sappino A, Vassalli P: Requirement of tumor necrosis factor for development of silica-induced pulmonary fibrosis. Nature 344: 245–247, 1990
Gossart S, Cambon C, Orfila C, Seguelas MH, Lepert JC: Reactive oxygen intermediates as regulators of TNF-α production in rat lung inflammation induced by silica. J Immunol 156: 1540–1548, 1996
Schmidt JA, Oliver CN, Lepe-Zuniga JL, Green I, Gery I: Silica-stimulated monocytes release fibroblast proliferation factors identical to interleukin 1. A potential role for interleukin 1 in the pathogenesis of silicosis. J Clin Invest 73: 1462–1472, 1984
Savici D, He B, Geist LJ, Monick MM, Hunninghake GW: Silica increases tumor necrosis factor (TNF) production, in part, by upregulating the TNF promoter. Exp Lung Res 20: 613–625, 1994
Borm PJA, Palmen N, Engelen JJM, Buurman WA: Spontaneous and stimulated release of tumor necrosis factor-alpha (TNF) from blood monocytes of miners with coal workers pneumoconiosis. Am Rev Respir Dis 138: 1589–1594, 1988
Schins RP, Borm PJ: Epidemiological evaluation of monocyte TNFalpha as an exposure and effect marker in pneumoconiosis: A five year follow up study of coal workers. Occup Environ Med 52: 441–450, 1995
Kim KA, Lim Y, Kim JH, Kim EK, Chang HS, Park YM, Ahn BY: Potential biomarker of coal workers' pneumoconiosis. Eur Respir J 8: 834–842, 1995
Lasalle P, Gosset P, Aerts C, Fournier E, Lafitte JE, Degreef JM, Wallaert B, Tonnel AB, Voisin C: Abnormal secretion of interleukin-1 and tumor necrosis factor-α by alveolar macrophages in coal workers' pneumoconiosis: Comparison between simple pneumoconiosis and progressive massive fibrosis. Exp Lung Res 16: 73–80, 1990
Vanhee D, Gosset P, Boitelle A, Wallaert B, Tonnel AB: Cytokines and cytokine network in silicosis and coal workers' pneumoconiosis. Eur Respir J 8: 834–842, 1995
Katsnelson BA, Polzik EV, Privalova LI: Some aspects of the problem of individual predisposition to silicosis. Environ Health Perspect 68: 175–185, 1986
Kornman KS, Crane A, Wang H-Y, di Giovine FS, Newman MG, Pirk FW, Wilson TG, Higginbottom FL, Duff GW: The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol 24: 72–77, 1997
Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J: A TaqI polymorphism in the human interleukin-1β (IL-1β gene correlates with IL-1β secretion in vitro. Eur J Clin Invest 22: 396–402, 1992
Danis VA, Millington M, Hyland VJ, Grennan D: Cytokine production by normal monocytes: Inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 99: 303–310, 1995
Perrey C, Pravica V, Sinnott PJ, Hutchinson IV: Genotyping for polymorphisms in interferon-γ, interleukin-10, transforming growth factor-β1 and tumour necrosis factor-α genes: A technical report. Trans Immunol 6: 193–197, 1998
Carrol MC, Katzman P, Alicot EM, Koller BH, Geraghty DE, Orr HT, Strominger JL, Spies T: Linkage map of the human major histocompatibility complex including the tumor necrosis factor genes. Proc Natl Acad Sci USA 84: 8535–8539, 1987
Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Potte LB, Duff GW: An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and D3 alleles. J Exp Med 177: 557–560, 1993
D'Alfonso S, Richiardi PM: A polymorphic variation in a putative regulation box of the TNF-α promoter region. Immunogenetics 3: 150–154, 1994
McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwiatkowski D: Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 371: 508–511, 1994
Cabrera M, Shaw MA, Sharples C, Williams H, Castes M, Convit J, Blackwell JM: Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med 182: 1259–1264, 1995
McManus R, Wilson AG, Mansfield J, Weir DG, Duff GW, Kelleher D: TNF2, a polymorphism of the tumour necrosis-α gene promoter, is a component of the celiac disease major histocompatibility complex haplotype. Eur J Immunol 26: 2113–2118, 1996
Huang S-L, Su C-H, Chang S-C: Tumor necrosis factor-α gene polymorphism in chronic bronchitis. Am J Respir Crit Care Med 156: 1436–1439, 1997
Arias AI, Giles B, Eiermann TH, Sterry W, Pandey JP: Tumor necrosis factor-alpha gene polymorphism in psoriasis. Exp Clin Immunogenet 14: 118–122, 1997
Sullivan KE, Wooten C, Schmeckpeper Goldman D, Petri MA: A promoter polymorphism of tumor necrosis factor-α associated with systemic lupus erythematosus in African-Americans. Arthritis Rheum 40: 2207–2211, 1997
Zhai R, Jetten M, Schins RPF, Franssen H, Borm PJA: Polymorphisms in the promoter of the tumor necrosis factor-α gene in coal miners. Am J Indust Med 34: 318–324 1998
Pociot F, Briant L, Jongeneel CV, Molvig J, Worsaae H, Abbal M, Thomsen M, Nerup J, Cambon-Thomsen A: Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-α and TNF-β by human mononuclear cells: A possible link to insulin-dependent diabetes mellitus. Eur J Immunol 23: 224–231, 1993
Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO: Heritable major histocompatibilty complex classII-associated differences in production of tumor necrosis factor-α: Relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 87: 1233–1237, 1990
Kroeger KM, Carville KS, Abraham LJ: The tumor necrosis factor-α promoter polymorphism effects transcription. Mol Immunol 34: 391–399, 1997
Roux-Lombard P: The interleukin-1 family. Eur Cytokine Netw 9: 565–576, 1998
Blakemore AIF, Tarlow JK, Cork MJ, Gordon C, Emery P, Duff GW: Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arth Rheum 37: 1380–1385, 1994
Mansfield JC, Holden H, Tarlow JK, di Giovine FS, McDowell TL, Wilson AG, Holdsworth CD, Duff GW: Novel genetic association between ulcerative colitis and the anti-inflammmatory cytokine interleukin-1 receptor antagonist. Gastroenterology 106: 637–642, 1994
Clay FE, Cork MJ, Tarlow JK, Blakemore AIF, Harrington CI, Lewis F, Duff GW: Interleukin 1 receptor antagonist gene polymorphism association with lichen sclerosis. Hum Genet 94: 407–410, 1994
Tarlow JK, Clay FE, Cork MJ, Blakemore AIF, McDonagh AJG, Messenger AG, Duff GW: Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene. J Invest Dermatol 103: 387–390, 1994
McDowell TL, Symons JA, Ploski R, Forre O, Duff GW: A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1α polymorphism. Arthritis Rheum 38: 221–228, 1995
Jouvenne P, Chaudhary A, Buchs N, di Giovine FS, Duff GW, Miossec P: Possible genetic association between interleukin-1α gene polymorphism and the severity of chronic polyarthritis. Eur Cytokine Netw 10: 33–36, 1999
Di Giovine FS, Cork MJ, Crane A, Mee JB, Duff GW: Novel genetic association of an IL-1β gene variation at +3953 with IL-1β protein production and psoriasis. Cytokine 7: 606, 1995
Gualde N, De Leobardy J, Serizay B, Malinvaud O: HL-A and silicosis. Am Rev Respir Dis 116: 334–336, 1977
Koskinen H, Tiilikainen A, Nordman H: Increased prevalence of HLAAw19 and the phenogroup Aw19, B18 in advanced silicosis. Chest 83: 848–852, 1983
Honda K, Kimura A, Dong R-P, Tamai H, Nagato H, Nishimura Y, Sasazuki T: Immunogenetic analysis of silicosis in Japan. Am J Respir Cell Mol Biol 8: 106–111, 1993
Rihs HP, Lipps P, May-Taube K, Jager D, Schmidt EW, Hegemann JH, Baur X: Immunogenetic studies on HLA-DR in German coal miners with and without coal workers' pneumoconiosis. Lung 172: 347–354, 1994
Wordsworth P, Bell J: Polygenic susceptibility in rheumatoid arthritis. Ann Rheum Dis 50: 343–346, 1991
Yucesoy B, Vallyathan V, Landsittel DP, Sharp DS, Weston A, Burleson G, Simeonova PP, McKinstry M, Luster MI: Association of TNF-α and IL-1 gene polymorphisms with silicosis. Toxicol Appl Pharmacol 172: 75–82, 2001
Yucesoy B, Vallyathan V, Landsittel DP, Sharp DS, Matheson JM, Burleson F, Luster MI: Polymorphisms of the IL-1 gene complex in coal miners with silicosis. Am J Ind Med 39: 286–291, 2001
Casini-Raggi V, Kam L, Chong YJT, Fiocchi C, Pizarro TT, Cominelli F: Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. J Immunol 154: 2434–2440, 1995
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yucesoy, B., Vallyathan, V., Landsittel, D.P. et al. Cytokine polymorphisms in silicosis and other pneumoconioses. Mol Cell Biochem 234, 219–224 (2002). https://doi.org/10.1023/A:1015987007360
Issue Date:
DOI: https://doi.org/10.1023/A:1015987007360